Konstantin V. Zhdanov

194044, Academic Lebedev Str. 9
Saint Petersburg, SPE 194044, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Pathogenetic aspects of autoantibody formation to central nervous system structures in patients with encephalitis

Pathogenetic aspects of autoantibody formation to central nervous system structures in patients with encephalitis

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: May 12, 2025

Serotype dynamics of Streptococcus pneumoniae in some countries in Eastern Europe and Central Asia.

Serotype dynamics of Streptococcus pneumoniae in some countries in Eastern Europe and Central Asia.

Journal: Vaccine

Published: November 15, 2024

Prediction of the course of antibiotic-associated diarrhea caused by Clostridioides difficile based on clinical and laboratory characteristics of the disease

Prediction of the course of antibiotic-associated diarrhea caused by Clostridioides difficile based on clinical and laboratory characteristics of the disease

Journal: Terapevticheskii arkhiv

Published: October 19, 2024

Safety and immunogenicity of GamEvac-Combi, a heterologous rVSV- and rAd5-vectored Ebola vaccine: a randomized controlled multicenter clinical trial in the Republic of Guinea and Russia.

Safety and immunogenicity of GamEvac-Combi, a heterologous rVSV- and rAd5-vectored Ebola vaccine: a randomized controlled multicenter clinical trial in the Republic of Guinea and Russia.

Journal: Frontiers in immunology

Published: August 27, 2024

Results of a randomized double-blind multicenter clinical trial of the efficacy and safety of riamilovir in the treatment of COVID-19

Results of a randomized double-blind multicenter clinical trial of the efficacy and safety of riamilovir in the treatment of COVID-19

Journal: Terapevticheskii arkhiv

Published: May 29, 2024

Results of a randomized double-blind multicenter clinical trial of the efficacy and safety of the drug riamilovir for the prevention of COVID-19

Results of a randomized double-blind multicenter clinical trial of the efficacy and safety of the drug riamilovir for the prevention of COVID-19

Journal: Terapevticheskii arkhiv

Published: April 16, 2024

Clinical efficiency and safety of riamilovir under various dosage regimens for treatment of acute respiratory viral infections in adults

Clinical efficiency and safety of riamilovir under various dosage regimens for treatment of acute respiratory viral infections in adults

Journal: Terapevticheskii arkhiv

Published: November 16, 2023

The experience in treatment of dengue fever using antiviral drug riamilovir in the Republic of Guinea (case report)

The experience in treatment of dengue fever using antiviral drug riamilovir in the Republic of Guinea (case report)

Journal: Terapevticheskii arkhiv

Published: February 24, 2023

Analysis of fatal outcomes of meningococcal infection in adults

Analysis of fatal outcomes of meningococcal infection in adults

Journal: Terapevticheskii arkhiv

Published: December 25, 2022

Prospects of using the nucleoside analogue riamilovir in patients with SARS-CoV-2 infection.

Prospects of using the nucleoside analogue riamilovir in patients with SARS-CoV-2 infection.

Journal: Terapevticheskii arkhiv

Published: November 22, 2022

General dynamics of the URT microbiome and microbial signs of recovery in COVID-19 patients.

General dynamics of the URT microbiome and microbial signs of recovery in COVID-19 patients.

Journal: Beneficial microbes

Published: November 22, 2022

Hepatobiliary system and intestinal injury in new coronavirus infection (COVID-19): A retrospective study.

Hepatobiliary system and intestinal injury in new coronavirus infection (COVID-19): A retrospective study.

Journal: World journal of clinical cases

Published: September 29, 2022

Showing 1-12 of 35

Last Updated: 09/26/2026